Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Baroda BNP Paribas Health and Wellness Fund Growth
NAV: 26 Aug '26
₹10.79
Min. for SIP
₹500
Fund size (AUM)
₹519.48 Cr
Expense ratio
2.79%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,431 | +2.87% | |
| 6 months | ₹30,000 | ₹32,239 | +7.46% | |
| 1 year | ₹60,000 | ₹66,126 | +10.21% |
Holdings (32)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.82% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 8.58% |
| Divi's Laboratories Ltd | Healthcare | Equity | 6.66% |
| Lupin Ltd | Healthcare | Equity | 6.46% |
| Ipca Laboratories Ltd | Healthcare | Equity | 5.72% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.35% |
| Laurus Labs Ltd | Healthcare | Equity | 5.24% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.55% |
| Astrazeneca Pharma India Ltd | Healthcare | Equity | 4.05% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.44% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 3.12% |
| Mankind Pharma Ltd. | Healthcare | Equity | 3.09% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 3.04% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 2.53% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.47% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 2.46% |
| Abbott India Ltd | Healthcare | Equity | 2.41% |
| Net Receivables | Unspecified | Net Receivables | 2.41% |
| Max Financial Services Ltd | Financial | Equity | 2.27% |
| Ami Organics Ltd | Healthcare | Equity | 2.15% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.05% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 1.74% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 1.46% |
| Inventurus Knowledge Solutions Ltd. | Industrials | Equity | 1.42% |
| Ajanta Pharma Ltd | Healthcare | Equity | 1.40% |
| Gland Pharma Ltd | Healthcare | Equity | 1.20% |
| Cipla Ltd | Healthcare | Equity | 1.13% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 1.11% |
| Medplus Health Services Ltd | Healthcare | Equity | 1.09% |
| Others CBLO | Unspecified | CBLO | 0.98% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 0.96% |
| Procter & Gamble Health Ltd | Healthcare | Equity | 0.64% |
See All
Minimum investments
Min. for 1st investment
₹1,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹500
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +5.7% | +13.3% | +7.6% | +6.7% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 20 | 23 | 25 | -- |
Exit load, stamp duty and tax
Exit load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
RKRohan KordeMay 2026 - PresentView details
RK
Rohan Korde
May 2026 - Present
View details
APAnkeet PandyaJul 2026 - PresentView details
AP
Ankeet Pandya
Jul 2026 - Present
View details
About Baroda BNP Paribas Health and Wellness Fund Growth
Baroda BNP Paribas Health and Wellness Fund Growth is a Equity Mutual Fund Scheme launched by Baroda BNP Paribas Mutual Fund. This scheme was made available to investors on 15 Apr 2004. Rohan Korde is the Current Fund Manager of Baroda BNP Paribas Health and Wellness Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹52,968 Cr and the Latest NAV as of 26 Aug 2026 is ₹10.79.
The Baroda BNP Paribas Health and Wellness Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹500. Minimum Lumpsum Investment is ₹1,000. Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
;
Investment Objective
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
Fund benchmarkBSE Healthcare Total Return Index
Fund house
Rank (total assets)#25 in India
Total AUM₹52,967.51 Cr
Date of Incorporation15 Apr 2004
Launch Date15 Apr 2004
AddressBNP Paribas House,7th Floor, G-Block,Bandra Kurla Complex, Bandra Mumbai 400051
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,